# Skeletal Muscle Dysfunction in Rheumatoid Arthritis (RA)

> **NCT02535832** · PHASE1 · COMPLETED · sponsor: **Ohio State University** · enrollment: 16 (actual)

## Conditions studied

- Rheumatoid Arthritis
- Insulin Resistance

## Interventions

- **DRUG:** Pioglitazone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02535832
- **Lead sponsor:** Ohio State University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2022-10
- **Final completion:** 2022-10
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2023-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02535832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02535832, "Skeletal Muscle Dysfunction in Rheumatoid Arthritis (RA)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02535832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*